Reports confirm that Vienna Insurance has missed its estimates with its profit figures dropping by almost 85% due to flooding.
In the today's statements coming from the company, the officials have confirmed that the Austria's biggest insurer i. e. Vienna Insurance Group AG (VIG)'s second-quarter profit have gone extremely down.
They have blamed the central European floods for such loss, which they said have proved worst for the company with tripling requests for damage compensation coming up. As an effect of the news, the shares of the company have also witnessed a fall.
According to the officials' reports, the company's profit for the period ending June 30 fell by 69 percent reaching to 46.3 million euros ($61.4 million). With the above figures, it has been confirmed that Vienna Insurance has missed out the estimate of 67.8 million-euro averagely that was made by five analysts.
Bloomberg data revealed that the company's net income has drastically fallen down by 85 percent reaching to only 16.7 million euros. Moreover, the premiums also fell by 8.4 percent reaching to 2.3 billion euros.
Weather-related "damages were three times as high as in the same period of the previous year," Vienna Insurance said. Till now, the insurer has received flood claims worth 180 million euros. The total weather-related claims stand at 230 million euros.
In its annual Environmental Responsibility Report for fiscal year 2015 released last Thursday, tech giant Apple has revealed that nearly 90 million pounds of unwanted or broken electronics were processed by the company over the last one year....
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
The Michael J Fox Foundation is aiming to test wearable sensors in smart watches made by Intel's...
There was a time just a few years back when Spain ranked second after Greece, as a figure of the euro zone's huge debt crisis and economic slowdown. The country's unemployment climbed to a huge twenty seven percent and the economy was still...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
On Tuesday, tech giant Google released latest to show how much of its online traffic is...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
There are a lot of things not going right at the IRS and...
On Thursday, the US Federal Bureau of Investigation (FBI...
In an announcement made via a blog post on Thursday,...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).